The Library
Structural features of the glutamate binding site in recombinant NR1/NR2A N-Methyl-d-aspartate receptors determined by site-directed mutagenesis and molecular modeling
Tools
Chen, Philip E., Geballe, Matthew T., Stansfeld, Phillip J., Johnston, Alexander R., Yuan, Hongjie, Jacob, Amanda L., Snyder, James P., Traynelis, Stephen F. and Wyllie, David J. A. (2005) Structural features of the glutamate binding site in recombinant NR1/NR2A N-Methyl-d-aspartate receptors determined by site-directed mutagenesis and molecular modeling. Molecular Pharmacology, 67 (5). pp. 1470-1484. doi:10.1124/mol.104.008185 ISSN 0026-895X.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1124/mol.104.008185
Abstract
We have used site-directed mutagenesis of amino acids located within the S1 and S2 ligand binding domains of the NR2A N-methyl-d-aspartate (NMDA) receptor subunit to explore the nature of ligand binding. Wild-type or mutated NR1/NR2A NMDA receptors were expressed in Xenopus laevis oocytes and studied using two electrode voltage clamp. We investigated the effects of mutations in the S1 and S2 regions on the potencies of the agonists l-glutamate, l-aspartate, (R,S)-tetrazol-5yl-glycine, and NMDA. Mutation of each of the corresponding residues found in the NR2A receptor subunit, suggested to be contact residues in the GluR2 α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit, caused a rightward shift in the concentration-response curve for each agonist examined. None of the mutations examined altered the efficacy of glutamate as assessed by methanethiosulfonate ethylammonium potentiation of agonist-evoked currents. In addition, none of the mutations altered the potency of glycine. Homology modeling and molecular dynamics were used to evaluate molecular details of ligand binding of both wild-type and mutant receptors, as well as to explore potential explanations for agonist selectivity between glutamate receptor subtypes. The modeling studies support our interpretation of the mutagenesis data and indicate a similar binding strategy for l-glutamate and NMDA when they occupy the binding site in NMDA receptors, as has been proposed for glutamate binding to the GluR2 AMPA receptor subunit. Furthermore, we offer an explanation as to why “charge conserving” mutations of two residues in the binding pocket result in nonfunctional receptor channels and suggest a contributing molecular determinant for why NMDA is not an agonist at AMPA receptors.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) | ||||
Journal or Publication Title: | Molecular Pharmacology | ||||
ISSN: | 0026-895X | ||||
Official Date: | 2005 | ||||
Dates: |
|
||||
Volume: | 67 | ||||
Number: | 5 | ||||
Page Range: | pp. 1470-1484 | ||||
DOI: | 10.1124/mol.104.008185 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |